Download - Evonik Industries

More documents

Recommendations

Info

42 neWs Student project presented in Marl A group of students from the Technical University Dortmund has created plans for a production plant for highly pure 1-butene at Marl Chemical Park. The students received support for their project assignment from Evonik’s Advanced Intermediates Business Unit’s Innovation Management. Students taking the course in bio and chemical engineering at the TU Dortmund are required to take part in a group project assignment to conceptualize a specialty chemicals plant. They have only six weeks to complete their assignment, which entails composing the process-related design and defining the dimensions of a facility, with its columns, reactors, receptacles, heat exchangers, pumps, and compressors, as well as devising layouts, optimizing energy utilization at their facility, and doing the cost and economic-feasibility accounting. It has become something of a tradition for the Innovation Management team at the elements39 Issue 2|2012 Jason Chan (second from left), head of the raffinate facility, detailed Performance Intermediate’s integrated C4 operations Advanced Intermediates Business Unit to put forward its proposal for the project to the university’s Technical Chemistry Chair, Prof. Arno Behr. This involvement adds to the practical character of the assignment, while it also serves as a proverbial bridge between academia and industry. What’s more, the collaboration allows the students to subsequently make the comparison between their finished theoretical concept, as devised on the basis of information available to them from literary sources, with actual facilities operating in practice at Marl Chemical Park. In 2011 the Innovation Management team’s project proposal was for the conceptualization of a facility for the manufacture of highly pure 1-butene. The Performance Intermediates Business Line runs an integrated C4 facility at the Marl site. Aside from butadienes, MTBE, isononanol, and diisononyl phthalate (DINP), a plasticizer, this, the only plant of its kind anywhere in the world, also More than 400 offshore pipes with veStAMID® nrG VESTAMID® NRG 1001, a high-performance polymer, can already be found in a total of over 800 kilometers of pipeline. The polyamide 12 made by Evonik Industries has gone into the making of more than 400 unbonded flexible pipes to service the oil production industry. Oil companies have been using these pipes in their offshore projects for years now. What has made the polyamide 12 molding compound so popular are its superior properties over those of other polyamides used as barrier layers in flexible pipes. Together with Wellstream International Limited, Evonik conducted intensive testing to demonstrate compliance with the international norms API 17J for flexible risers and ISO 13628-2. The tests praised the creep performance, ductility, thermal expansion, methanol compatibility, and hydrolysis resistance. The molding compound has since been used commercially for the manufacture of flexible pipes. Specially developed VESTAMID® NRG combines its technical advantages with extraordinarily consistent product quality, which ensures outstanding processability and thus reduces setup times, scrap, and the risk of extrusion faults. For decades now, Evonik has been a leader in the development and marketing of high-grade polyamide compounds for line systems in motor vehicles. This high degree of expertise in the development of extrusion compounds has now been carried over to molding compounds for the thick-walled piping systems which, thanks to their advantages over existing systems, are increasingly coming into use in the oil and gas industries. Flexible: Offshore pipes with veStAMID® nrG makes 1-butene. 1-butene is a key comonomer used predominantly to make high-grade polyethylene and poly-1-butene. The students executed their group assignment in the 2011/2012 winter semester. They then visited Marl Chemical Park for a guided tour by Jason Chan, head of the raffinate facility, who detailed the integrated C4 operations to them. This group of aspiring young academics proved to be particularly fascinated by the two 80- meter-high columns at the heart of 1-butene production. The group was then invited to present its own concept to an audience comprising staff members from the business unit’s Production, Engineering, and Research teams and from Process Technology and Engineering. The students impressed this audience with the sound quality of their completed work. The discussion which followed addressed the differences apparent between the students’ concept and a real facility and also brought forth a number of tips concerning practical considerations. The participants all agreed that educational elements of this kind on the student curriculum help to make studies more practice-oriented as well as providing a platform for contact between industry and students. Thus, the scheme sees the Innovation Manage ment unit making a valuable contribution to Evonik’s em ployer branding endeavors.
Creavis starts with new BISOn project The Biotechnological Synthesis of Carbo xyamines and Carboxyalcohols Project, or “BISON” for short, was launched at the end of last year. Creavis Technologies & Inno va tion’s Science-to-Business Center (S2B) Bio technology is in charge of the project, the aim of which is to use biotechnology to modify molecules that could be used for polymer building blocks or fine chemicals in the future. Creavis is the strategic research and development unit of Evonik. Both renewable and petroleum-based raw materials are used as starting materials in the BISON project. Customized microorganisms then convert and modify these materials to produce the desired end product. The actual modification of the molecules is done by selective oxidation and amination–or what is also known as biotransformation. BISON involves experts from the fields of microbiology, protein engineering, and process development. Working with the Tech nical Credits Publisher Evonik Industries AG Corporate Innovation Strategy & Management Rellinghauser Straße 1–11 45128 Essen Germany scientific Advisory Board Dr. Norbert Finke Corporate Innovation Strategy & Management norbert.finke@evonik.com editor in Chief Dr. Karin Aßmann Evonik Services GmbH Editorial Department karin.assmann@evonik.com Contribution editors Christa Friedl Thomas Lange Michael Vogel neWs 43 University of Munich (Germany) and the S2B Center Biotechnology, the consortium will develop the microbial cell factory for a future generation of production processes that promise to be more sustainable than the former process in the chemical in dustry. The German Federal Ministry of Edu cation and Research (BMBF) is funding the project, which will run for three years. This project owes its success to the Car boxyFun project, which did well and was also funded by the BMBF. In the future, BISON will take the findings from Car boxyFun and transfer them to other biotechnological processes so that the microbial cell factory can become reality. Biotechnological processes are gaining in popularity in the chemical industry. One of the reasons for this is that the biotech processes involve lower investment costs than chemical processes. This means, for example, that multi-level production stages can be mapped in a single bacterium cell–the microbial cell factory. Photos Evonik Industries Karsten Bootmann Dirk Bannert Martin Daniels Dieter Debo Stefan Wildhirt Eurotec (p. 35) Wellstream (p. 42) Fotolia.com/Uwe Annas (p. 2, 11) Corbis/Imaginechina (p. 6) Fotolia.com/lunamarina (p. 38) Fotolia.com/mirpic (p. 38) Fotolia.com/Berni (p. 39) Fotolia.com/graham tomlin (p. 39) A glance into a laboratory of the Creavis’ Science- to-Business Center Biotechnology in Marl design Michael Stahl, Munich (Germany) Printed by Laupenmühlen Druck GmbH & Co. KG Bochum (Germany) Reproduction only with permission of the editorial office Evonik Industries is a worldwide manufacturer of PMMA products sold under the PLEXIGLAS® trademark on the European, Asian, African, and Australian continents and under the ACRYLITE® trademark in the Americas elements39 Issue 2|2012
Page 1 and 2: elements39 Quarterly Science newsle
Page 3 and 4: esources In 2011, Evonik generated
Page 5 and 6: “Tablets and sprays are more conv
Page 7 and 8: “There’s no success without tru
Page 9 and 10: “If you want to develop advanced
Page 11 and 12: work of the project houses focuses
Page 13 and 14: cessing method for an innovative ap
Page 15 and 16: ficantly smaller piece counts, they
Page 17 and 18: On the way to the market cipating b
Page 19 and 20: sorrow were still part of everyday
Page 21 and 22: Honorary professorship for Dr. Klau
Page 23 and 24: evonik invests in High-tech Gründe
Page 25 and 26: it Remains a challenge for catalysi
Page 27 and 28: Figure 3 Performance profiles of va
Page 29 and 30: Patients Who suffeR from stomach or
Page 31 and 32: In permanent bending tests, veStAKe
Page 33 and 34: dr. Markus Braun, 45, is a trained
Page 35 and 36: nologies. The sandwich structure wi
Page 37 and 38: Left: One rapidly growing market th
Page 39 and 40: says Fengler. “And we don’t all
Page 41: At an exhibition in Darmstadt, the

Download - Evonik Industries

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?